Amodeo, Valeria, A, Deli, Betts, Joanne, Bartesaghi, Stefano, Zhang, Ying, Richard-Loendt, Angela, Ellis, Matthew, Roshani, Rozita, Vouri, Mikaela, Galavotti, Sara, Oberndorfer, Sarah, Leite, Ana Paula, Mackay, Alan, Lampada, Aikaterini, Stratford, Eva Wessel, Li, Ning Ning, Dinsdale, David, Grimwade, David, Jones, Chris, Nicotera, Pierluigi, Michod, David, Brandner, Sebastian and Salomoni, Paolo (2017) A PML/Slit axis controls physiological cell migration and cancer invasion in the CNS. Cell Reports, 20 (2), 411-426. (doi:10.1016/j.celrep.2017.06.047).
Abstract
Cell migration through the brain parenchyma underpins neurogenesis and glioblastoma (GBM) development. Since GBM cells and neuroblasts use the same migratory routes, mechanisms underlying migration during neurogenesis and brain cancer pathogenesis may be similar. Here, we identify a common pathway controlling cell migration in normal and neoplastic cells in the CNS. The nuclear scaffold protein promyelocytic leukemia (PML), a regulator of forebrain development, promotes neural progenitor/stem cell (NPC) and neuroblast migration in the adult mouse brain. The PML pro-migratory role is active also in transformed mouse NPCs and in human primary GBM cells. In both normal and neoplastic settings, PML controls cell migration via Polycomb repressive complex 2 (PRC2)-mediated repression of Slits, key regulators of axon guidance. Finally, a PML/SLIT1 axis regulates sensitivity to the PML-targeting drug arsenic trioxide in primary GBM cells. Taken together, these findings uncover a drug-targetable molecular axis controlling cell migration in both normal and neoplastic cells.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.